Clinical trial
Combining Antidepressants and Attention Bias Modification in Depression: a Randomized Controlled Trial in Primary Care
NCT05503966 is registered in ClinicalTrials.gov with University of Oslo as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Combining Antidepressants and Attention Bias Modification in Depression: a Randomized Controlled Trial in Primary Care
- Lead sponsor
- University of Oslo
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- September 22, 2022
- Completion date
- December 30, 2025
- Enrollment
- 246 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.